Search clinical trials for: Hydroxychloroquine (HCQ)

Total 491 results

Shahid Beheshti University of Medical Sciences

Unknown

Favipiravir in Hospitalized COVID-19 Patients (FIC)

COVID-19

Iran, Islamic Republic of
Roberto Poscia MD, PhD

Unknown

Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora (PROBIOZOVID)

Coronavirus Infection | Pneumonia, Viral | SARS-CoV 2 | COVID

Italy
Shahid Beheshti University of Medical Sciences

Unknown

Azithromycin in Hospitalized COVID-19 Patients (AIC)

COVID-19

Iran, Islamic Republic of
General and Teaching Hospital Celje

Unknown

Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia

Covid-19

Slovenia
Sheba Medical Center

Unknown

Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus (COSTA)

COVID - 19

Israel
University of Sao Paulo General Hospital

Unknown

Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System (PostCOVID19)

Pneumonia | Myocardial Injury | Corona Virus Infection | COVID19

Brazil
Shahid Beheshti University of Medical Sciences

Unknown

Umifenovir in Hospitalized COVID-19 Patients (UAIIC)

COVID-19

Iran, Islamic Republic of
Shahid Beheshti University of Medical Sciences

Unknown

Interferon Beta 1a in Hospitalized COVID-19 Patients (IB1aIC)

COVID-19

Iran, Islamic Republic of
Oslo University Hospital

Unknown

The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

COVID 19 | SARS-CoV Infection | Acute Respiratory Distress Syndrome ARDS

Norway
Fasa University of Medical Sciences

Unknown

Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19

COVID-19

Iran, Islamic Republic of
Shanghai Public Health Clinical Center

Completed

Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19

COVID-19 | Coronavirus | Pneumonia, Pneumocystis

China
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients (ONCOVID)

Cancer & COVID 19

France
Intermountain Health Care, Inc.
University of Utah; Utah Department of Health

Unknown

Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 (HyAzOUT)

COVID-19

United States
Prof. Dr. Umar Farooq
Ayub Medical College, Abbottabad

Unknown

Effectiveness of Hydroxychloroquine in Covid-19 Patients (Covid)

COVID19

Pakistan
Elena Gonzalez Brant, MD
University of Pittsburgh

Completed

Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa

Hidradenitis Suppurativa | Hidradenitis | Boils | Acne Inversa | Follicular Occlusion Triad | Follicular Occlusion Tetrad

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Leonard Appleman
Prometheus Laboratories

Completed

Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

Metastatic Renal Cell Carcinoma

United States
Instituto de Cardiologia do Rio Grande do Sul
Hospital de Clinicas de Porto Alegre

Unknown

Anti-Inflammatory Drug and Endothelial Function (HOLD)

Cardiovascular Diseases | Coronary Artery Disease | Atherosclerosis | Sleep Apnea | Endothelial Dysfunction

Brazil
National and Kapodistrian University of Athens

Completed

Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome

Antiphospholipid Syndrome

Greece
Royal Liverpool University Hospital
National Institute for Health Research, United Kingdom; National Association...

Completed

Antibiotics and Hydroxychloroquine in Crohn's (APRiCCOT)

Crohn's Disease

United Kingdom
Nanfang Hospital of Southern Medical University

Unknown

Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs

Ankylosing Spondylitis | Spondyloarthritis

China
University of Leeds

Completed

Very Early Versus Delayed Etanercept in Patients With RA (VEDERA)

Rheumatoid Arthritis

United Kingdom
University Hospital Center of Martinique

Completed

Lupus and Observance (LUPOBS)

Systemic Lupus, Skin Lupus

France
Assiut University

Unknown

Hydroxychloroquine Efficacy on Behcet's Disease Thrombosis

Behcet's Syndrome, Vascular Type

Egypt
The Eye Center and The Eye Foundation for Research...
King Khalid University Hospital

Completed

Hydroxychloroquine Dosing and Toxicity in Ophthalmology Clinics

Hydroxychloroquine Toxic Retinopathy

Saudi Arabia
Universitaire Ziekenhuizen KU Leuven

Unknown

Effect of Bitter in Overweight Female Volunteers (PLAQOW)

Obesity
Universitaire Ziekenhuizen KU Leuven

Unknown

Effect of Hydroxychloroquine Sulphate in Healthy Lean Females (PLAQHV)

Obesity
Amer Zureikat
National Institutes of Health (NIH)

Completed

Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas

Pancreatic Cancer

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment

Unspecified Adult Solid Tumor, Protocol Specific

United States
Nathan Bahary, MD

Completed

Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine

Pancreatic Cancer

United States
Hoffmann-La Roche

Completed

A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis

Rheumatoid Arthritis

Greece
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis (SAIL)

Lymphangioleiomyomatosis

United States
Tanta University

Unknown

Proliferative Lupus Nephritis Treatment With Chloroquine and Hydroxychloroquine

Proliferative Nephritis | Chloroquine Retinopathy

Egypt
First Affiliated Hospital of Harbin Medical University

Unknown

Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence

Atrial Fibrillation

China
Stanford University

Completed

Hydroxychloroquine/Atorvastatin in the Treatment of Osteoarthritis (OA) of the Knee

Osteoarthritis of the Knee

United States
Assiut University

Completed

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

Immune Thrombocytopenia

Egypt
Alison Sehgal, MD, MS

Terminated

Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous Leukemia

Leukemia, Acute Myelogenous

United States
Peking University First Hospital

Completed

A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Hydroxychloroquine | IgA Patients

China
Dr. S.S. Michel Clinic

Completed

Monitoring and Preventing Hydroxychloroquine, Plaquenil, Toxicity.

Hydroxychloroquine Toxicity

Canada
Western Regional Medical Center

Terminated

Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy (ABC01)

Estrogen Receptor Positive Breast Cancer

United States
Peking Union Medical College Hospital

Unknown

Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy (HCQIgAN)

Primary IgA Nephropathy

China
OHSU Knight Cancer Institute
National Cancer Institute (NCI)

Completed

Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Sanofi
Regeneron Pharmaceuticals

Completed

To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)

Rheumatoid Arthritis

Hungary, Portugal, Austria, United States, Argentina, Australia, Brazil, Canada, Czechia, Germany, Greece, Guatemala, Israel, Italy, Korea, Republic of, Lithuania, Mexico, New Zealand, Peru, Poland, Romania, Russian Federation, Spain, Taiwa... and more
Sanofi
Regeneron Pharmaceuticals

Completed

To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)

Rheumatoid Arthritis

United States, Argentina, Belgium, Brazil, Czechia, Estonia, Finland, Hungary, Israel, Italy, Mexico, Netherlands, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom, Norway
Sanofi
Regeneron Pharmaceuticals

Completed

To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis (SARIL-RA-EASY)

RA

United States, Chile, Mexico, Poland, Russian Federation, South Africa
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
University of Pittsburgh

Completed

Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer (REHNIS)

Insulin Resistance

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); AbbVie; Rutgers Cancer Institute of New Jersey

Terminated

Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer

Prostate Cancer

United States
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Immunosuppression | Rheumatism

Search clinical trials for: Hydroxychloroquine (HCQ)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations